PUBLISHER: DelveInsight | PRODUCT CODE: 2167725
PUBLISHER: DelveInsight | PRODUCT CODE: 2167725
Catheter Stabilization/Securement Device Market Summary
Catheter stabilization and securement devices are products used to anchor and secure intravascular and other catheters in place, preventing movement, migration, and accidental dislodgement that can lead to complications, reinsertion, and infection. These devices replace or supplement traditional suturing and simple tape, offering engineered, sutureless securement that improves safety and reduces needlestick risk. The category spans adhesive anchor securement devices that attach the catheter hub to the skin, integrated securement dressings that combine a transparent dressing with securement and, in some cases, antimicrobial protection, and tissue adhesive or cyanoacrylate-based securement. Devices are designed for specific catheter applications, including peripherally inserted central catheters and central venous catheters, arterial lines, Foley urinary catheters, epidural catheters, and general or multipurpose use. Catheter securement is central to infection prevention and vascular access management across hospitals and home care. Over the past decade, the field has advanced from sutures and tape toward engineered adhesive devices, integrated antimicrobial securement dressings, and subcutaneous and tissue-adhesive securement, establishing these devices as an essential component of safe catheter care worldwide.
Catheter Stabilization/Securement Device Market Key Growth Drivers
Key Companies in Catheter Stabilization/Securement Device Market
The competitive landscape is led by the following active manufacturers and solution providers:
Factors Contributing to the Growth of the Catheter Stabilization/Securement Device Market
Market Drivers
Rising Use of Vascular Access and Other Catheters
The escalating use of catheters across healthcare is the foundational driver of securement device demand. Vascular access is among the most common invasive procedures in healthcare, with over 1 billion peripheral intravenous catheters placed worldwide each year, alongside large volumes of peripherally inserted central catheters, central venous catheters, arterial lines, urinary catheters, and epidural catheters. Every catheter placed requires securement to prevent movement and dislodgement, creating a direct and recurring demand for stabilization devices. The rising prevalence of chronic diseases, cancer, and conditions requiring intravenous therapy, along with growing surgical and hospital admission volumes, continues to increase catheter use. As the volume of catheter placements rises with an aging population and expanding access to care, the need for securement devices grows correspondingly. The sheer scale and continued growth of catheter use across hospital and home settings create durable and expanding demand for stabilization and securement devices, reinforcing sustained market growth throughout the forecast period.
Focus on Preventing Catheter Dislodgement and Bloodstream Infections
The clinical and economic imperative to prevent catheter complications is a powerful driver of securement device adoption. Accidental catheter dislodgement is a common and costly problem that leads to therapy interruption, painful reinsertion, and increased infection risk, and central line-associated bloodstream infections are a serious, largely preventable cause of morbidity, mortality, and cost. Effective securement reduces catheter micromotion at the insertion site, a key contributor to both dislodgement and infection, and engineered securement devices have been shown to reduce complications compared with sutures and tape. Health systems face financial penalties and quality reporting requirements tied to healthcare-associated infections, strengthening the incentive to adopt securement. Infection prevention programs increasingly standardize on engineered securement as part of vascular access bundles. As the focus on patient safety, infection prevention, and complication reduction intensifies, demand for effective catheter securement is expected to grow, driving market expansion across the forecast period.
Market Restraints
Despite steady demand, the Catheter Stabilization/Securement Device market faces material constraints. The devices are relatively low-cost, high-volume consumables, and pricing pressure and commoditization at the lower end compress margins and limit revenue growth relative to unit volume. Reimbursement for securement is typically bundled into broader procedure or per-diem payments rather than reimbursed separately, which can discourage the adoption of premium engineered devices in cost-sensitive settings. Medical adhesive-related skin injury is a recognized complication of adhesive securement devices and dressings, particularly in patients with fragile skin, and concerns about skin integrity can limit use or require additional skin protection products. Adoption varies across institutions and regions, and some settings continue to rely on tape or sutures due to cost, habit, or limited awareness, slowing the transition to engineered securement. The effectiveness of securement depends on proper application and maintenance, requiring clinician training and adherence to protocols. Competition among numerous manufacturers of similar devices intensifies price competition. Regulatory requirements under frameworks such as the European Medical Device Regulation raise evidence and compliance burdens. Finally, uneven access to advanced securement products and vascular access expertise in emerging markets and cost-constrained settings restrains the pace of adoption across parts of the sector.
Catheter Stabilization/Securement Device Market Segment Analysis
The Catheter Stabilization/Securement Device Market is segmented by product type (picc and cvc stabilization, foley stabilization, arterial stabilization, multipurpose stabilization, epidural stabilization, others), securement type (adhesive securement devices, integrated securement dressings, tissue adhesive securement, others), end-user (hospitals, homecare settings, others), and geography (North America, Europe, Asia-Pacific, Rest of World).
By Product Type
Dominant Subsegment: PICC and CVC Stabilization.
The PICC and CVC stabilization segment accounted for 37% of the Catheter Stabilization/Securement Device market in 2025. Securement for peripherally inserted central catheters and central venous catheters dominates because these central vascular access devices carry the highest risk and cost from dislodgement and central line-associated bloodstream infection, and they typically remain in place for extended dwell times, making reliable securement essential. The large and growing volume of central line placements for chemotherapy, long-term antibiotics, parenteral nutrition, and dialysis, together with the strong clinical and regulatory focus on preventing central line infections, concentrates demand in this segment. Engineered securement devices such as adhesive anchor systems and integrated antimicrobial dressings are standard components of central line care bundles. Foley urinary catheter stabilization represents a large-volume segment, and arterial, epidural, and multipurpose stabilization serve additional catheter applications, while other applications add further demand. Nonetheless, the high clinical risk, extended dwell times, infection-prevention priority, and guideline focus associated with central lines secure the leadership of the PICC and CVC stabilization segment across the forecast period.
By Securement Type
Dominant Subsegment: Adhesive Securement Devices.
The adhesive securement devices segment accounted for 56% of the Catheter Stabilization/Securement Device market in 2025. Adhesive anchor securement devices, which attach the catheter hub to the skin with an adhesive-backed anchor pad, dominate because they are the established, versatile, and widely adopted engineered alternative to sutures and tape across catheter types. Market-leading products such as BD's StatLock and universal adhesive devices such as Grip-Lok anchor a broad range of catheters and are entrenched in hospital vascular access practice. Their versatility, ease of application, and strong clinical evidence for reducing dislodgement and complications underpin their leading share. Integrated securement dressings, which combine a transparent dressing with securement and, in some products, chlorhexidine antimicrobial protection, are an important and growing segment, exemplified by securement dressings from Solventum and others, particularly for central lines. Tissue adhesive, or cyanoacrylate-based securement, offered by companies such as Adhezion Biomedical, is an emerging approach that bonds the catheter at the insertion site. Nonetheless, the versatility, established adoption, and clinical evidence of adhesive anchor devices secure the segment's leadership across the forecast period, with integrated dressings and tissue adhesives growing alongside.
Catheter Stabilization/Securement Device Market Region Analysis
Dominant Region: North America
North America accounted for 43% of the global Catheter Stabilization/Securement Device market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects high catheter utilization, advanced infection-prevention practices, and early adoption of engineered securement devices. The United States leads on the strength of a large volume of vascular access procedures, strong regulatory and quality focus on preventing central line-associated bloodstream infections, and the presence of leading securement manufacturers. Guidelines from the Centers for Disease Control and Prevention and the Infusion Nurses Society recommending engineered securement are widely followed, and financial penalties tied to healthcare-associated infections reinforce adoption. The regulatory environment is well defined, with the Food and Drug Administration providing established pathways for securement devices. The market benefits from mature vascular access teams and infection prevention programs, and a concentration of manufacturers, including Becton, Dickinson and Company, whose StatLock is a market benchmark, and Solventum. The growth of home infusion further supports demand. This combination of high utilization, infection-prevention focus, and manufacturer presence reinforces North America's leadership in the global market.
Fastest Growing Region: Asia-Pacific
Asia-Pacific is the fastest-growing region in the Catheter Stabilization/Securement Device market. The region's elevated CAGR is driven by large populations, rising healthcare access, and expanding hospital and vascular access capacity across China, Japan, India, South Korea, and Australia. Growing healthcare investment, increasing surgical and hospital admission volumes, and rising awareness of infection prevention and catheter-related complications are accelerating adoption of engineered securement devices. The rising prevalence of chronic diseases requiring long-term intravenous access, together with expanding cancer care and dialysis, is increasing catheter use across the region. Both global manufacturers and regional providers are expanding their presence with securement devices and cost-effective options tailored to local requirements, and improving infection-prevention practice is broadening adoption beyond major urban centers. Government initiatives to improve patient safety and reduce healthcare-associated infections further support growth. The combination of large patient populations, rising catheter use, and increasing infection-prevention focus positions Asia-Pacific as the highest-growth region over the forecast period.
Regional Commentary
North America
North America accounted for 43% of the global Catheter Stabilization/Securement Device market revenue in 2025. The United States dominates the region on the strength of high catheter utilization, strong infection-prevention practice and guidelines, financial incentives to reduce healthcare-associated infections, and the presence of leading manufacturers, while Canada advances through public healthcare infection-prevention programs and Mexico expands hospital capacity within its growing healthcare sector.
Europe
Europe represents the second-largest regional market, led by Germany, the United Kingdom, and France. Growth is supported by established infection-prevention practice, high catheter utilization, and the presence of major manufacturers such as B. Braun and Convatec, while the European Medical Device Regulation shapes requirements for securement devices.
Asia-Pacific
Asia-Pacific is the fastest-growing region, propelled by large populations, rising healthcare access, and expanding hospital and vascular access capacity across China, Japan, India, South Korea, and Australia. Rising infection-prevention awareness and increasing catheter use are broadening adoption of engineered securement devices.
Rest of World
The Rest of World region, spanning the Middle East, Africa, and South America, is an emerging growth frontier. Rising healthcare investment, gradual improvements in hospital and infection-prevention infrastructure, and increasing availability of securement devices are expanding access, while patient-safety initiatives support the broader adoption of catheter securement.
Catheter Stabilization/Securement Device Market Competitive Landscape
The Catheter Stabilization/Securement Device market is classified as Moderately Concentrated. A group of large medical device companies holds significant positions, led by Becton, Dickinson and Company, whose StatLock is a market benchmark, and Solventum through its securement dressings, followed by Baxter, B. Braun, Cardinal Health, Convatec, and Merit Medical, with specialized securement providers such as Starboard Medical, Dale Medical Products, and Adhezion Biomedical, and additional regional players. The competitive landscape can be evaluated across the following dimensions:
Catheter Stabilization/Securement Device Market Recent Developmental Activities
In 2024, Solventum Corporation was established as an independent company through the spin-off of 3M's health care business, including its Tegaderm securement dressing and skin-integrity portfolio. Strategic significance: Creates a focused health care company with a leading integrated securement dressing and infection-prevention franchise.
Catheter Stabilization/Securement Device Market Segmentation
Catheter Stabilization/Securement Device Market by Product Type
Catheter Stabilization/Securement Device Market by Securement Type
Catheter Stabilization/Securement Device Market by End-User
Catheter Stabilization/Securement Device Market by Geography
Key Takeaways from the Catheter Stabilization/Securement Device Market Report Study
Target audience who can benefit from this catheter stabilization/securement device market report study
Q1. What is the growth rate of the Catheter Stabilization/Securement Device market?
The Catheter Stabilization/Securement Device market is projected to expand at a CAGR of 6.3% during the forecast period of 2026-2034.
Q2. What is the market size of the Catheter Stabilization/Securement Device market?
The Catheter Stabilization/Securement Device market is estimated at USD 1.88 billion in 2025 and is projected to reach USD 3.27 billion by 2034.
Q3. Which region dominates the Catheter Stabilization/Securement Device market?
North America dominated the Catheter Stabilization/Securement Device market with a 43% share of global revenue in 2025, supported by high catheter utilization, strong infection-prevention practices and guidelines, financial incentives to reduce healthcare-associated infections, and the presence of leading manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.
Q4. What are the key drivers of the Catheter Stabilization/Securement Device market?
The principal drivers are the rising use of vascular access catheters, with over 1 billion peripheral catheters placed worldwide each year; the clinical and regulatory focus on preventing catheter dislodgement and central line-associated bloodstream infections; guideline support from the Centers for Disease Control and Prevention and the Infusion Nurses Society for engineered securement; and the shift from sutures to sutureless securement, reinforced by aging populations and the growth of home infusion.
Q5. Who are the major players in the Catheter Stabilization/Securement Device market?
The major players include Becton, Dickinson and Company, Solventum Corporation, Baxter International Inc., B. Braun SE, Cardinal Health, Inc., Convatec Group PLC, Merit Medical Systems, Inc., Starboard Medical, Inc., Dale Medical Products, Inc., and Adhezion Biomedical, LLC, among other active manufacturers and solution providers profiled in the Competitive Landscape section. BD's StatLock is a market benchmark, and Solventum leads in integrated securement dressings.
For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.